DailyDoctor Archive Specialties Get app
Back to the 5 October 2026 edition

Research · 03 of 05

Skin nerve loss tracks cognition in Parkinson's disease

Note skin small-fibre loss as a possible marker of central neurodegeneration in Parkinson's, but do not use skin biopsy to assess cognition yet.

Design
Cross-sectional, single-centre; skin biopsy, neuropsychology and MRI
Population
155 patients with Parkinson's disease across cognitive stages and 50 controls
Primary outcome
Association of nerve fibre density with cognition and brain volume
Effect
Fibre density 7.18 (control) to 3.40 (dementia) fibres/mm; impairment odds ratio 0.54 (0.42-0.70); AUC 0.77

A cross-sectional study at a Chinese movement-disorders centre compared 155 patients with Parkinson's disease, across normal cognition, mild cognitive impairment and dementia, with 50 healthy controls, using skin-biopsy intraepidermal nerve fibre density, cognitive testing and structural MRI.

Nerve fibre density fell stepwise across the cognitive spectrum (healthy 7.18, normal cognition 5.89, mild impairment 4.65, dementia 3.40 fibres/mm) and correlated with global and domain cognitive scores. Lower density independently predicted cognitive impairment and distinguished impaired from unimpaired patients reasonably well (area under the curve 0.77); frontal and insular grey-matter volumes partly mediated the link.

The interest is conceptual: peripheral small-fibre pathology may mirror central neurodegeneration, a peripheral-central axis in Parkinson's. It is cross-sectional and single-centre, so this is a research signal, not a reason to start ordering skin biopsies to assess cognition.

  • Intraepidermal nerve fibre density fell stepwise from healthy controls to Parkinson's dementia.
  • Lower density independently predicted cognitive impairment (odds ratio 0.54 per unit).
  • It distinguished impaired from unimpaired patients with an area under the curve of 0.77.
  • Frontal and insular atrophy partly mediated the nerve-cognition link.
  • This is a research signal, not a clinical test for cognition in Parkinson's.

Why it matters

It links a measurable peripheral finding to central disease, suggesting the periphery may reflect brain neurodegeneration in Parkinson's.

Don't overread it

This is cross-sectional and single-centre; it shows association, not that skin denervation causes or predicts cognitive decline over time.

The statistics, in plain English

An odds ratio below 1 per unit of nerve density means more fibres go with lower risk; a cross-sectional design shows association at one timepoint and cannot establish that denervation precedes or causes cognitive decline.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

dementiamovementstroke

Tomorrow morning, before your first patient

One edition a day for neurology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app